BD Worldwide
About BD
Contact BD
Careers
Products
Investors
News & Media
Privacy
Terms & Conditions
Site Map
Advanced Search
Europe
Select another location
Diagnostic Systems
About Us
Products
Global Initiatives
Services
News & Events
Contact Us
Diagnostic Systems Home
Cancer
Growth and AST
HAI
Sepsis
STI
Tuberculosis
Industry
HAI Archive
E-mail
Print
31 March, 2012
New Assay Rapidly Identifies Lethal Pathogen Responsible for Clostridium difficile Infection
24 November, 2011
First Healthcare-Associated Infection Assay on the BD MAX™ System Launches in Europe
27 September, 2011
World MRSA Day
24 August, 2011
BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System
24 August, 2011
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System
24 July, 2011
BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians
24 July, 2011
BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System
20 November, 2009
BD Completes Acquisition of HandyLab, Inc.
23 October, 2009
BD Announces Agreement to Acquire HandyLab, Inc.
7 October, 2009
Literature References
6 August, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio »
18 May, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays »
7 July, 2008
BD GeneOhm™ Cdiff Assay CE Marked and Submitted for FDA Clearance
Europe
